色素-话题@MedSci

#色素#

654篇内容 | 6264人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1680637, encodeId=e2b2168063ef5, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Artif Cells Nanomed Biotechnol ：CTRP3抑制高浓度葡萄糖诱导的视网膜色素上皮细胞的氧化应激和细胞凋亡, objectType=article, longId=180206, objectId=77da18020613, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=77da18020613, replyNumber=0, likeNumber=95, createdTime=2020-06-03, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=77da18020613, moduleTitle=Artif Cells Nanomed Biotechnol ：CTRP3抑制高浓度葡萄糖诱导的视网膜色素上皮细胞的氧化应激和细胞凋亡, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=77da18020613)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680650, encodeId=7ee7168065093, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=J Clin Oncol：III期试验：Ipilimumab辅助疗法与大剂量干扰素α-2b用于高风险黑色素瘤的优劣对比, objectType=article, longId=185702, objectId=43a9185e0237, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43a9185e0237, replyNumber=0, likeNumber=125, createdTime=2020-01-20, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43a9185e0237, moduleTitle=J Clin Oncol：III期试验：Ipilimumab辅助疗法与大剂量干扰素α-2b用于高风险黑色素瘤的优劣对比, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=43a9185e0237)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680677, encodeId=7b8e16806e7d0, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=女，12岁，色素性青光眼病例, objectType=article, longId=196728, objectId=6ba5196e28a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ba5196e28a9, replyNumber=0, likeNumber=73, createdTime=2020-09-30, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ba5196e28a9, moduleTitle=女，12岁，色素性青光眼病例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ba5196e28a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680629, encodeId=448816806295c, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Lancet Oncol：研究5年随访结果显示：帕博利珠单抗为晚期黑色素瘤患者带来长期生存获益, objectType=article, longId=177116, objectId=c4f01e7116dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c4f01e7116dc, replyNumber=0, likeNumber=79, createdTime=2020-03-14, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c4f01e7116dc, moduleTitle=Lancet Oncol：研究5年随访结果显示：帕博利珠单抗为晚期黑色素瘤患者带来长期生存获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c4f01e7116dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680659, encodeId=06371680659fa, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=以骨转移灶症状为首发表现的恶性黑色素瘤1例, objectType=article, longId=188833, objectId=b53c1888335f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b53c1888335f, replyNumber=0, likeNumber=130, createdTime=2020-09-09, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b53c1888335f, moduleTitle=以骨转移灶症状为首发表现的恶性黑色素瘤1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b53c1888335f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680647, encodeId=73bc168064ebf, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=从疗效到机制，达拉非尼+曲美替尼治疗中国黑色素瘤患者更具优势, objectType=article, longId=184053, objectId=2bb91840533a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2bb91840533a, replyNumber=0, likeNumber=67, createdTime=2020-06-09, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2bb91840533a, moduleTitle=从疗效到机制，达拉非尼+曲美替尼治疗中国黑色素瘤患者更具优势, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2bb91840533a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680668, encodeId=aee616806687d, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Cell Death Dis：环状RNA Circ_0002770高表达预示黑色素瘤患者预后不良, objectType=article, longId=193915, objectId=54c41939154a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=54c41939154a, replyNumber=0, likeNumber=120, createdTime=2020-10-02, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=54c41939154a, moduleTitle=Cell Death Dis：环状RNA Circ_0002770高表达预示黑色素瘤患者预后不良, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=54c41939154a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680634, encodeId=b54d16806344b, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=原发性食管恶性黑色素瘤伴十二指肠转移一例, objectType=article, longId=178057, objectId=cb521e805710, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb521e805710, replyNumber=0, likeNumber=60, createdTime=2019-08-26, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb521e805710, moduleTitle=原发性食管恶性黑色素瘤伴十二指肠转移一例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb521e805710)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680661, encodeId=f1551680661d3, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=君实生物特瑞普利单抗联合阿昔替尼治疗黏膜黑色素瘤获得美国FDA孤儿药资格认定, objectType=article, longId=191029, objectId=251b191029aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=251b191029aa, replyNumber=0, likeNumber=64, createdTime=2021-03-08, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=251b191029aa, moduleTitle=君实生物特瑞普利单抗联合阿昔替尼治疗黏膜黑色素瘤获得美国FDA孤儿药资格认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=251b191029aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680633, encodeId=ca0e168063319, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Sci transl med：MDM2拮抗剂可克服黑色素瘤对CDK4/6抑制剂的耐药性, objectType=article, longId=178015, objectId=77ed1e8015f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=77ed1e8015f9, replyNumber=0, likeNumber=70, createdTime=2019-11-10, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=77ed1e8015f9, moduleTitle=Sci transl med：MDM2拮抗剂可克服黑色素瘤对CDK4/6抑制剂的耐药性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=77ed1e8015f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680651, encodeId=e77016806511f, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=皮肤及肢端恶性黑色素瘤外科诊治, objectType=article, longId=185824, objectId=8e5b185824bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e5b185824bb, replyNumber=0, likeNumber=73, createdTime=2020-10-20, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e5b185824bb, moduleTitle=皮肤及肢端恶性黑色素瘤外科诊治, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8e5b185824bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680625, encodeId=a5391680625ef, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=枯木逢春：氟苯达唑或能有效抑制黑色素瘤的生长和扩散, objectType=article, longId=175503, objectId=bd741e550335, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bd741e550335, replyNumber=0, likeNumber=71, createdTime=2019-08-26, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bd741e550335, moduleTitle=枯木逢春：氟苯达唑或能有效抑制黑色素瘤的生长和扩散, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bd741e550335)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680618, encodeId=e416168061812, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Lancet oncol：新辅助药物达拉非尼联合曲美替尼疗法用于III期黑色素瘤的疗效评估, objectType=article, longId=167652, objectId=245216e65298, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=245216e65298, replyNumber=0, likeNumber=54, createdTime=2020-01-28, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=245216e65298, moduleTitle=Lancet oncol：新辅助药物达拉非尼联合曲美替尼疗法用于III期黑色素瘤的疗效评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=245216e65298)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680612, encodeId=46cd1680612e7, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=脑内原发黑色素瘤伴出血1例, objectType=article, longId=165405, objectId=d70916540575, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d70916540575, replyNumber=0, likeNumber=59, createdTime=2019-09-19, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d70916540575, moduleTitle=脑内原发黑色素瘤伴出血1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d70916540575)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680658, encodeId=9e4f1680658a9, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=2020年ASCO-SITC：针对高危黑色素瘤患者的个体化疫苗取得喜人结果, objectType=article, longId=187728, objectId=50b618e7282f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=50b618e7282f, replyNumber=0, likeNumber=71, createdTime=2020-06-21, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=50b618e7282f, moduleTitle=2020年ASCO-SITC：针对高危黑色素瘤患者的个体化疫苗取得喜人结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=50b618e7282f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680609, encodeId=d5a71680609fd, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Cell Rep：黑素脱失患者来源多能性干细胞的自体移植治疗 -色素恢复与皮肤功能重建取得重大突破, objectType=article, longId=164050, objectId=f08c16405025, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f08c16405025, replyNumber=0, likeNumber=70, createdTime=2019-06-20, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f08c16405025, moduleTitle=Cell Rep：黑素脱失患者来源多能性干细胞的自体移植治疗 -色素恢复与皮肤功能重建取得重大突破, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f08c16405025)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680655, encodeId=c158168065523, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=2019 欧洲多学科共识指南：黑色素瘤的治疗（更新版）, objectType=article, longId=187067, objectId=761d18e067c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=761d18e067c1, replyNumber=0, likeNumber=17, createdTime=2020-05-12, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=761d18e067c1, moduleTitle=2019 欧洲多学科共识指南：黑色素瘤的治疗（更新版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=761d18e067c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680623, encodeId=98fb16806239e, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Targovax宣布在抗PD1难治性黑色素瘤患者中，溶瘤病毒ONCOS-102联合Keytruda取得了令人鼓舞的结果, objectType=article, longId=175100, objectId=a3a71e5100ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3a71e5100ff, replyNumber=0, likeNumber=73, createdTime=2019-09-26, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3a71e5100ff, moduleTitle=Targovax宣布在抗PD1难治性黑色素瘤患者中，溶瘤病毒ONCOS-102联合Keytruda取得了令人鼓舞的结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a3a71e5100ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680616, encodeId=148f168061693, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=小细胞低色素性贫血，一表分清四种病因, objectType=article, longId=166539, objectId=eb6b166539de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb6b166539de, replyNumber=0, likeNumber=73, createdTime=2020-04-12, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb6b166539de, moduleTitle=小细胞低色素性贫血，一表分清四种病因, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb6b166539de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680617, encodeId=f327168061e1f, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=早期精准诊断：4分钟读懂黑色素瘤BRAF突变检测的重要性, objectType=article, longId=167433, objectId=128b16e43377, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=128b16e43377, replyNumber=0, likeNumber=72, createdTime=2019-11-15, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=128b16e43377, moduleTitle=早期精准诊断：4分钟读懂黑色素瘤BRAF突变检测的重要性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=128b16e43377)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

色素

2020-05-29

sunylz (审核中...)

前往app查看评论内容

#色素#

Artif Cells Nanomed Biotechnol ：CTRP3抑制高浓度葡萄糖诱导的视网膜色素上皮细胞的氧化应激和细胞凋亡

2020-06-03

sunylz (审核中...)

前往app查看评论内容

#色素#

J Clin Oncol：III期试验：Ipilimumab辅助疗法与大剂量干扰素α-2b用于高风险黑色素瘤的优劣对比

2020-01-20

sunylz (审核中...)

前往app查看评论内容

#色素#

女，12岁，色素性青光眼病例

2020-09-30

sunylz (审核中...)

前往app查看评论内容

#色素#

Lancet Oncol：研究5年随访结果显示：帕博利珠单抗为晚期黑色素瘤患者带来长期生存获益

2020-03-14

sunylz (审核中...)

前往app查看评论内容

#色素#

以骨转移灶症状为首发表现的恶性黑色素瘤1例

2020-09-09

sunylz (审核中...)

前往app查看评论内容

#色素#

从疗效到机制，达拉非尼+曲美替尼治疗中国黑色素瘤患者更具优势

2020-06-09

sunylz (审核中...)

前往app查看评论内容

#色素#

Cell Death Dis：环状RNA Circ_0002770高表达预示黑色素瘤患者预后不良

2020-10-02

sunylz (审核中...)

前往app查看评论内容

#色素#

原发性食管恶性黑色素瘤伴十二指肠转移一例

2019-08-26

sunylz (审核中...)

前往app查看评论内容

#色素#

君实生物特瑞普利单抗联合阿昔替尼治疗黏膜黑色素瘤获得美国FDA孤儿药资格认定

2021-03-08

sunylz (审核中...)

前往app查看评论内容

#色素#

Sci transl med：MDM2拮抗剂可克服黑色素瘤对CDK4/6抑制剂的耐药性

2019-11-10

sunylz (审核中...)

前往app查看评论内容

#色素#

皮肤及肢端恶性黑色素瘤外科诊治

2020-10-20

sunylz (审核中...)

前往app查看评论内容

#色素#

枯木逢春：氟苯达唑或能有效抑制黑色素瘤的生长和扩散

2019-08-26

sunylz (审核中...)

前往app查看评论内容

#色素#

Lancet oncol：新辅助药物达拉非尼联合曲美替尼疗法用于III期黑色素瘤的疗效评估

2020-01-28

sunylz (审核中...)

前往app查看评论内容

#色素#

脑内原发黑色素瘤伴出血1例

2019-09-19

sunylz (审核中...)

前往app查看评论内容

#色素#

2020年ASCO-SITC：针对高危黑色素瘤患者的个体化疫苗取得喜人结果

2020-06-21

sunylz (审核中...)

前往app查看评论内容

#色素#

Cell Rep：黑素脱失患者来源多能性干细胞的自体移植治疗 -色素恢复与皮肤功能重建取得重大突破

2019-06-20

sunylz (审核中...)

前往app查看评论内容

#色素#

2019 欧洲多学科共识指南：黑色素瘤的治疗（更新版）

2020-05-12

sunylz (审核中...)

前往app查看评论内容

#色素#

Targovax宣布在抗PD1难治性黑色素瘤患者中，溶瘤病毒ONCOS-102联合Keytruda取得了令人鼓舞的结果

2019-09-26

sunylz (审核中...)

前往app查看评论内容

#色素#

小细胞低色素性贫血，一表分清四种病因

2020-04-12

sunylz (审核中...)

前往app查看评论内容

#色素#

早期精准诊断：4分钟读懂黑色素瘤BRAF突变检测的重要性

2019-11-15

科室
- - 订阅+
  - 更多科室
工具
服务